Shipped from their warehouse in Germany, arrived day 5, documentation complete.
SWB — Shanghai Wibson Biotechnology Co., Ltd.
Shanghai, CN · established 2019. The index holds 317 assay reports across 50 batches and 27 compounds, contributed by 6 laboratories. Every figure below is computed from those records and from nothing else.
Where SWB sells
Shanghai Wibson Biotechnology Co., Ltd. sells from its own storefront. The link is marked nofollow and sponsored: it exists so the figures on this scorecard can be read against what the supplier itself publishes. The index is paid nothing for it and a link is not an assessment.
Visit SWB at shanghaiwibsonbiotechnology.net →
Every figure above describes lots the index has seen. It says nothing about the lot you are offered, and the only check that does is the one on the certificate against the vial.
Identification
Business facts, held constant across the index and not derived from the data. The index sells nothing and takes no supplier payment for placement; the storefront link below is marked nofollow and sponsored so a record can be checked against the seller, and is not a recommendation.
- Legal name
- Shanghai Wibson Biotechnology Co., Ltd.
- Short code in this index
- SWB
- Also known as
- SWB · SWB Biotech · Shanghai Wibson Biotechnology
- City
- Shanghai
- Region
- Shanghai
- Country
- CN
- Established
- 2019
- First record in index
- 02 May 2024
- Most recent record
- 13 Oct 2026
Dispatch and warehouses
Where the supplier holds regional stock. Material assayed by the index is dispatched from these locations, not from the manufacturing site.
- Netherlands (Rotterdam) — European Union, 2-4 days
- Germany (Hamburg) — Germany, Austria, Switzerland, 2-4 days
- United Kingdom (London) — United Kingdom & Ireland, 2-3 days
- United States (California) — United States, 2-4 days
- Canada (Toronto) — Canada, 3-5 days
- Australia (Melbourne) — Australia & New Zealand, 3-5 days
Headline statistics
Each figure carries the n it was computed from. The n= badge next to a statistic is the number of records it was computed from. Below n=8 the badge is amber. Below n=3 the statistic is suppressed and the individual values are shown instead.
Reproducibility across independent tests of one lot
Where the same physical lot was assayed more than once, the spread between those results is a property of the material and the fill, not of the market. It is the rarest and most informative statistic on this page, and it exists only for lots someone tested twice.
Across the 40 SWB lots in the index with three or more independent assays, the median spread between the highest and lowest purity result on one lot is 1.10 pp. Interpreting that number requires the laboratory repeatability figures: the best contributing laboratory here repeats to 0.16 pp and the worst to 0.34 pp, so a within-lot spread under about 0.5 pp is indistinguishable from measurement noise and a spread above 1 pp is a statement about the material.
Supplier certificate against independent measurement
The supplier's own COA purity figure for a lot, minus the median of the index's independent observations of the same physical lot. Positive means the certificate reads higher than the measurement. Rule AX-R05 fires above 1.5 pp.
Provenance — where the tested material came from
Supplier-supplied samples are weaker evidence than independently purchased ones, because the supplier chose the vial. The index measures the size of that effect rather than assuming it.
Documentation completeness
The score is not an opinion about paperwork. Each component is the share of SWB batches in the index whose certificate carries that field, weighted as set out on the scoring rubric.
| Certificate field | Batches carrying it | Rubric weight | |
|---|---|---|---|
| Purity figure stated | 100% | 25 points | |
| Analytical method stated (column, gradient, wavelength) | 78% | 25 points | |
| Peptide content stated | 72% | 20 points | |
| Endotoxin stated | 36% | 15 points | |
| Named impurities rather than a total | 46% | 15 points |
Coverage by compound
The delta column is this supplier's median minus the index-wide median for the same compound, which is the only comparison worth making: comparing a supplier's aggregate against another supplier's aggregate compares their product mixes as much as their process control.
| Compound | Class | Reports | Median % | Index median % | Δ (pp) | Index spec | Pass % |
|---|---|---|---|---|---|---|---|
| Semaglutide | Incretin | 47 | 98.66 | 98.87 | -0.21 | 97.0 | 100 |
| Melanotan II | Melanocortin-receptor | 38 | 99.46 | 99.24 | +0.22 | 98.5 | 97 |
| Retatrutide | Incretin | 22 | 98.48 | 98.41 | +0.08 | 96.5 | 100 |
| BPC-157 | Tissue-repair | 21 | 99.36 | 99.15 | +0.21 | 98.0 | 100 |
| Tirzepatide | Incretin | 16 | 98.63 | 98.44 | +0.19 | 97.0 | 88 |
| IGF-1 LR3 | Growth-hormone | 15 | 97.13 | 97.75 | -0.62 | 95.0 | 100 |
| IGF-1 DES (1-3) | Growth-hormone | 14 | 97.94 | 98.53 | -0.59 | 95.0 | 100 |
| NAD+ | Non-peptide | 12 | 98.97 | 98.88 | +0.09 | 97.0 | 100 |
| MGF | Growth-hormone | 12 | 98.41 | 98.73 | -0.32 | 97.5 | 100 |
| Selank | Neuroactive | 12 | 99.15 | 99.13 | +0.01 | 99.0 | 75 |
| 5-Amino-1MQ | Non-peptide | 12 | 99.28 | 99.24 | +0.04 | 98.0 | 100 |
| Ipamorelin | Growth-hormone | 12 | 99.85 | 99.48 | +0.37 | 99.0 | 100 |
| Kisspeptin-10 | Melanocortin-receptor | 10 | 98.56 | 99.27 | -0.70 | 98.5 | 60 |
| L-Glutathione (reduced) | Short | 10 | 98.78 | 99.00 | -0.21 | 98.5 | 90 |
| Thymosin α1 | Tissue-repair | 9 | 99.30 | 99.11 | +0.19 | 97.5 | 100 |
| AOD-9604 | Metabolic | 9 | 99.14 | 99.25 | -0.11 | 98.0 | 100 |
| Mazdutide | Incretin | 8 | 98.27 | 98.11 | +0.16 | 96.5 | 100 |
| N-Acetyl Semax Amide | Neuroactive | 7 n=7 | 99.50 | 99.26 | +0.24 | 98.5 | 100 |
| PT-141 (Bremelanotide) | Melanocortin-receptor | 7 n=7 | 99.10 | 99.31 | -0.22 | 98.5 | 100 |
| CJC-1295 with DAC | Growth-hormone | 5 n=5 | 98.56 | 98.79 | -0.23 | 97.5 | 100 |
| Gonadorelin | Hypothalamic | 5 n=5 | 98.62 | 99.28 | -0.66 | 98.5 | 80 |
| P21 | Neuroactive | 4 n=4 | 99.19 | 99.19 | 0.00 | 98.0 | 100 |
| MK-677 (Ibutamoren mesylate) | Non-peptide | 3 n=3 | 99.32 | 99.37 | -0.05 | 98.5 | 100 |
| Exenatide | Incretin | 2 n=2 | n<3 | 98.94 | — | 98.0 | 100 |
| CJC-1295 (no DAC) | Growth-hormone | 2 n=2 | n<3 | 98.61 | — | 98.0 | 100 |
| Enclomiphene citrate | Non-peptide | 2 n=2 | n<3 | 99.23 | — | 98.5 | 100 |
| Cagrilintide | Incretin | 1 n=1 | n<3 | 98.59 | — | 96.5 | 100 |
Full per-compound breakdown with distributions and caveats →
Quarterly trend
Submission volume is not market share and a quarterly median is not a trend unless the compound mix held still. Both caveats apply to every row below.
Median purity by quarter
Quarters with fewer than two purity records are gaps in the line rather than zeroes.
Coverage growth
Records added per quarter. Growth here is index coverage, not supplier volume.
| Quarter | Batches | Reports | Median purity | Range | Flagged |
|---|---|---|---|---|---|
| 2024-Q1 | 0 | 0 | n<3 | — | 0 |
| 2024-Q2 | 2 | 11 | 98.84 | 96.55–99.35 | 4 |
| 2024-Q3 | 3 | 16 | 99.06 | 98.52–99.90 | 9 |
| 2024-Q4 | 2 | 6 | 98.72 | 97.95–99.72 | 6 |
| 2025-Q1 | 4 | 27 | 99.17 | 97.50–99.93 | 18 |
| 2025-Q2 | 8 | 45 | 99.36 | 97.60–99.93 | 33 |
| 2025-Q3 | 5 | 24 | 99.30 | 98.77–99.93 | 9 |
| 2025-Q4 | 7 | 61 | 98.58 | 96.06–99.93 | 38 |
| 2026-Q1 | 8 | 63 | 99.03 | 97.07–99.93 | 47 |
| 2026-Q2 | 6 | 26 | 98.32 | 97.54–99.61 | 25 |
| 2026-Q3 | 5 | 38 | 98.93 | 97.97–99.93 | 35 |
Which laboratory produced these numbers
Laboratories disagree with each other by a measured amount. A supplier tested mostly by one laboratory carries that laboratory's offset in its aggregate, and the adjusted column removes it.
| Laboratory | Reports | Median purity | Lab bias (pp) | Bias-adjusted |
|---|---|---|---|---|
| Janoshik | 148 | 98.96 | +0.00 | 98.96 |
| PeptideMeter | 39 | 98.79 | -0.05 | 98.84 |
| Medutest | 57 | 99.14 | +0.08 | 99.06 |
| VendorInvestigate | 25 | 98.44 | -0.11 | 98.55 |
| Nordanalyt | 29 | 99.08 | +0.02 | 99.06 |
| Kestrel | 19 | 99.46 | +0.24 | 99.22 |
Bias figures are estimated from paired same-lot comparisons and are published with their confidence intervals on inter-lab agreement.
What this data does and does not show
On-the-record reviews 26
Reviews are signed statements from index contributors about their own testing of this supplier's material. They are opinions attached to evidence, and they are not used in any statistic on this page.
Arrived on day 2 against a quoted 3. Customs paperwork was right first time, which is why it moved that fast.
Documentation is complete and the numbers are steady. A dependable choice for routine work.
Queried the related-substances total on lot SWB-26-175; they came back with method, column and detection limit. That depth is rare.
The tirzepatide 10 mg arrived on day 3 with the cold pack intact and the seal unbroken. Straightforward, exactly as described.
Custom synthesis quote came back with a realistic timeline and they beat it. Purity on delivery matched the signed spec.
Steady supplier. Medutest results have agreed with their stated figures on every lot I have submitted.
Medutest has now seen 6 of their lots through me. Not one has come back outside spec.
Third order and it went the same way as the first two. Predictable in the way you want a supplier to be.
No customs paperwork, no import wait — it came from their stock in the United States and arrived day 3.
Their warehouse in the United States had the ipamorelin 5 mg in stock and it shipped the same afternoon. Tracking never left the country.
4 lots logged now, purity 98.8 to 99.0%. A band that tight is worth more to me than one spectacular number.
Lot code on the vial matched the lot code on the certificate exactly. Sounds basic; it is the single best predictor of everything else.
Solid on the retatrutide 5 mg. Purity where it should be, transit 4 days, paperwork in order.
Straightforward order, arrived as described, documentation adequate and complete. Nothing to add, which is the point.
First order, deliberately small, IGF-1 LR3 1 mg only. Documentation, transit and a Janoshik result at 99.4% all checked out, so the next one will not be small.
8 orders in eighteen months, no substitutions, no reformulations, everything in stock when the site said it was. Boring is the highest compliment I have.
Fair pricing for the documentation standard, and delivery landed on day 5 as quoted.
Asked a genuinely technical question about pre-dispatch storage and got a reply with numbers in it, inside 6 hours.
Same lot documentation as the factory ships, but out of their warehouse in the United Kingdom, so it landed on day 5.
Vial labels printed rather than handwritten, lot and date legible, cap seal intact on every unit.
Ordered semax 10 mg twice. Both vials reconstituted cleanly and both matched their certificates.
Certificate claimed 98.2% on lot SWB-25-303. Medutest came back 98.4%. On an independent column that is as close to agreement as this gets.
Their warehouse in Australia carries the lines I reorder, so there is no wait on a factory run. Day 4 every time.
Reordered on the strength of the last one and got an identical result. Repeatability is the product.
Asked them to hold an order until I confirmed a lot number and they did, without fuss and without a restocking charge.
Most recent records
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042461 | Kisspeptin-10 | SWB-2603-D6238 | Janoshik | 2026-Q3 | 98.35 | 4.65 | 96.5 | Supplier-supplied | 3 | FAIL |
| AX-2026-042479 | Melanotan II | SWB-2603-A5707 | Janoshik | 2026-Q3 | 99.16 | 3.67 | 94.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042481 | Melanotan II | SWB-2603-A5707 | Medutest | 2026-Q3 | 98.95 | 3.37 | 90.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042460 | Kisspeptin-10 | SWB-2603-D6238 | Kestrel | 2026-Q3 | 99.55 | 4.21 | 90.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042483 | Melanotan II | SWB-2603-A5707 | Janoshik | 2026-Q3 | 99.38 | 3.73 | 107.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042398 | Semaglutide | SWB-2602-X5278 | Nordanalyt | 2026-Q3 | 99.08 | 4.48 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042399 | Semaglutide | SWB-2602-X5278 | Janoshik | 2026-Q3 | 98.56 | 3.82 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042499 | BPC-157 | SWB-2607-Y5787 | Kestrel | 2026-Q3 | 99.93 | 4.25 | 94.4 | Supplier-supplied | 0 | PASS |
| AX-2026-042388 | Semaglutide | SWB-2602-X5278 | Nordanalyt | 2026-Q3 | 98.09 | 3.90 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042458 | Kisspeptin-10 | SWB-2603-D6238 | Kestrel | 2026-Q3 | 98.51 | 4.71 | 102.4 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042463 | Kisspeptin-10 | SWB-2603-D6238 | Nordanalyt | 2026-Q3 | 98.35 | 4.93 | 98.6 | Supplier-supplied | 3 | FAIL |
| AX-2026-042478 | Melanotan II | SWB-2603-A5707 | VendorInvestigate | 2026-Q3 | 98.73 | 4.34 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042482 | Melanotan II | SWB-2603-A5707 | Janoshik | 2026-Q3 | 99.22 | 4.66 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042465 | Kisspeptin-10 | SWB-2603-D6238 | Kestrel | 2026-Q3 | 99.03 | 4.83 | 96.4 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042462 | Kisspeptin-10 | SWB-2603-D6238 | Janoshik | 2026-Q3 | 98.61 | 4.73 | 96.5 | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042392 | Semaglutide | SWB-2602-X5278 | Janoshik | 2026-Q3 | 98.66 | 3.47 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042389 | Semaglutide | SWB-2602-X5278 | Medutest | 2026-Q3 | 98.21 | 4.47 | 99.8 | Supplier-supplied | 2 | FAIL |
| AX-2026-042396 | Semaglutide | SWB-2602-X5278 | Medutest | 2026-Q3 | 99.01 | 3.79 | 99.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042387 | Semaglutide | SWB-2602-X5278 | Medutest | 2026-Q3 | 99.58 | 3.81 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042394 | Semaglutide | SWB-2602-X5278 | Janoshik | 2026-Q3 | 99.67 | 4.90 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042390 | Semaglutide | SWB-2602-X5278 | Medutest | 2026-Q3 | 99.15 | 4.43 | 102.5 | Buyer-sourced | 2 | FAIL |
| AX-2026-042472 | Melanotan II | SWB-2603-A5707 | Janoshik | 2026-Q3 | 99.55 | 4.28 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042475 | Melanotan II | SWB-2603-A5707 | Janoshik | 2026-Q3 | 99.42 | 4.21 | 105.7 | Supplier-supplied | 0 | PASS |
| AX-2026-042500 | Exenatide | SWB-2603-D6146 | PeptideMeter | 2026-Q3 | 98.70 | 5.31 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042395 | Semaglutide | SWB-2602-X5278 | Janoshik | 2026-Q3 | 98.69 | 3.57 | 89.3 | Supplier-supplied | 2 | MARGINAL |